Literatur
Savolainen-Peltonen H, Rahkola-Soisalo P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS (2019) Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide casecontrol study. BMJ 364:l665
Maki PM (2013) Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies. Menopause 20(6):695–709
Henderson VW (2014) Alzheimer’s disease: review of hormone therapy trials and implications for treatment and prevention after menopause. J Steroid Biochem Mol Biol 142:99–106
Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH, S. Women’s Health Initiative Memory (2004) Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women’s Health Initiative Memory Study. JAMA 291(24):2947–2958
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
P. Stute gibt an, dass kein Interessenkonflikt besteht.
Additional information
Redaktion
Deutsche Menopause Gesellschaft e. V.
P. Stute, Bern
K. Schaudig, Hamburg
Rights and permissions
About this article
Cite this article
Stute, P. Reloaded – HRT und Alzheimer-Demenz. Gynäkologische Endokrinologie 18, 116–117 (2020). https://doi.org/10.1007/s10304-020-00304-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10304-020-00304-3